Causes of Death in People With Cardiovascular Disease: A UK Biobank Cohort Study

Michael Drozd1, Mar Pujades-Rodriguez2, Fei Sun3

  • 1Leeds Institute of Cardiovascular and Metabolic Medicine The University of Leeds Leeds UK.

Insights

Noncardiovascular deaths are common in individuals with cardiovascular diseases (CVD), with cancer being the leading cause. As CVD multimorbidity increases, so does the risk of cardiovascular and infection-related deaths, highlighting the need for personalized patient care.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Therapeutic advancements have decreased cardiovascular death rates.
  • Understanding noncardiovascular death causes in cardiovascular disease (CVD) patients is crucial.
  • Cardiovascular multimorbidity is an increasing concern.

Purpose of the Study:

  • To determine the rates of cardiovascular and noncardiovascular death in individuals with specified CVDs.
  • To analyze death causes in relation to the number of distinct CVDs present (cardiovascular multimorbidity).

Main Methods:

  • Utilized UK Biobank data from 493,280 UK residents.
  • Calculated proportions of death causes (cardiovascular, cancer, infection, other) based on 9 distinct self-reported CVDs.
  • Employed Poisson regression to determine adjusted incidence rate ratios for death causes, controlling for confounders.

Main Results:

  • Among 27,729 deaths, 20.4% were cardiovascular, 53.6% cancer, 5.0% infection, and 21.0% other causes.
  • Increased cardiovascular multimorbidity correlated with higher proportions of cardiovascular and infection-related deaths.
  • Individuals with ≥3 CVDs had significantly higher adjusted incidence rate ratios for cardiovascular (7.0), infection (4.4), cancer (1.5), and other (2.0) deaths compared to those without CVD.

Conclusions:

  • Noncardiovascular death is prevalent in patients with cardiovascular disease (CVD), with significant variation across different CVD types.
  • Cancer is the most common cause of death in this population.
  • Holistic and personalized care strategies are essential for improving outcomes in individuals with CVD.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
398
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
479
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
107
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
71
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
81
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.4K